{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:53:28Z","timestamp":1790830408318,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"TEVA Pharmaceuticals","award":["SRA #109415"],"award-info":[{"award-number":["SRA #109415"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS080152"],"award-info":[{"award-number":["R01NS080152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG055577"],"award-info":[{"award-number":["R01AG055577"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32NS093786"],"award-info":[{"award-number":["F32NS093786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-25-00024-\u041f"],"award-info":[{"award-number":["14-25-00024-\u041f"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.nbd.2018.12.022","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:47:15Z","timestamp":1545914835000},"page":"489-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-0730","authenticated-orcid":false,"given":"Daniel","family":"Ryskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1793-2205","authenticated-orcid":false,"given":"Dabin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Geva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.12.022_bb0005","first-page":"517","article-title":"Amelioration of the haloperidol-induced memory impairment and brain oxidative stress by cinnarizine","volume":"11","author":"Abdel-Salam","year":"2012","journal-title":"EXCLI J."},{"key":"10.1016\/j.nbd.2018.12.022_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer's","year":"2015","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.nbd.2018.12.022_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2018.12.022_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1471-4159.2009.06000.x","article-title":"Anti-amnesic properties of (\u00b1)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats","volume":"109","author":"Antonini","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.12.022_bb0025","first-page":"31","article-title":"Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology","volume":"2","author":"Bolshakova","year":"2016","journal-title":"Phys. Mathem."},{"key":"10.1016\/j.nbd.2018.12.022_bb0030","first-page":"1","article-title":"Neuroprotective effect of \u03c31-receptors on the cell model of Huntington's disease","author":"Bol'shakova","year":"2017","journal-title":"Bull. Exp. Biol. Med"},{"key":"10.1016\/j.nbd.2018.12.022_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.conb.2007.04.009","article-title":"Do thin spines learn to be mushroom spines that remember?","volume":"17","author":"Bourne","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20150934","article-title":"Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors","volume":"473","author":"Brailoiu","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2018.12.022_bb0045","doi-asserted-by":"crossref","first-page":"E2410","DOI":"10.1073\/pnas.1716189115","article-title":"Long-term potentiation expands information content of hippocampal dentate gyrus synapses","volume":"115","author":"Bromer","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jalz.2017.10.009","article-title":"Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2018.12.022_bb0055","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1021\/bi401575g","article-title":"The sigma enigma: in vitro\/in silico site-directed mutagenesis studies unveil sigma1 receptor ligand binding","volume":"53","author":"Brune","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0060","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/0269881111400648","article-title":"Behavioural phenotyping of knockout mice for the sigma-1 (\u03c31) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations","volume":"25","author":"Chevallier","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0065","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.12.022_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2009.11.025","article-title":"The dopaminergic stabilizers pridopidine (ACR16) and (\u2212)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties","volume":"628","author":"Dyhring","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/WNF.0b013e31821c31d8","article-title":"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease","volume":"34","author":"Esmaeilzadeh","year":"2011","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2012.04.046","article-title":"Association between a variant of the sigma-1 receptor gene and Alzheimer's disease","volume":"517","author":"Feh\u00e9r","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2018.12.022_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP","volume":"28","author":"Feng","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.12.022_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000440864","article-title":"AF710B, a novel M1\/\u03c31 agonist with therapeutic efficacy in animal models of Alzheimer's disease","volume":"16","author":"Fisher","year":"2016","journal-title":"Neurodegenerative Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0100","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.12.022_bb0105","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awu107","article-title":"Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism","volume":"137","author":"Francardo","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.12.022_bb0110","series-title":"Early Pridopidine Treatment Improves Behavioral and Transcriptional Deficits in YAC128 Huntington Disease Mice","author":"Garcia-Miralles","year":"2017"},{"key":"10.1016\/j.nbd.2018.12.022_bb0115","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddw238","article-title":"Pridopidine activates neuroprotective pathways impaired in Huntington Disease","volume":"25","author":"Geva","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.12.022_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/4789","article-title":"Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice","volume":"5","author":"Guo","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.12.022_bb0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jalz.2017.11.009","article-title":"AF710B, an M1\/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease","volume":"14","author":"Hall","year":"2017","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.nbd.2018.12.022_bb0130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.12.022_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature15257","article-title":"Labelling and optical erasure of synaptic memory traces in the motor cortex","volume":"525","author":"Hayashi-Takagi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.12.022_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.1106","article-title":"Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered","volume":"25","author":"Hindmarch","year":"2010","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.nbd.2018.12.022_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/156720511797633232","article-title":"Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease","volume":"8","author":"Huang","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2018.12.022_bb0150","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.25362","article-title":"A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease","volume":"28","author":"Huntington Study Group","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.12.022_bb0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(93)91441-T","article-title":"Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss","volume":"623","author":"Jansen","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2018.12.022_bb0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nprot.2006.86","article-title":"High Ca2+\u2212phosphate transfection efficiency in low-density neuronal cultures","volume":"1","author":"Jiang","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2018.12.022_bb0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.tins.2012.09.007","article-title":"The sigma-1 receptor: roles in neuronal plasticity and disease","volume":"35","author":"Kourrich","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer's disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.nbd.2018.12.022_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-018-0259-3","article-title":"Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse","volume":"13","author":"Kusko","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.12.022_bb0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","article-title":"Soluble A\u03b2 oligomers impair hippocampal LTP by disrupting glutamatergic\/GABAergic balance","volume":"85","author":"Lei","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(01)00194-5","article-title":"Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons","volume":"29","author":"Lu","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.12.022_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/msj.20160","article-title":"Amyloid-\u03b2 Oligomers: possible Roles as Key Neurotoxins in Alzheimer's Disease","volume":"77","author":"Lublin","year":"2010","journal-title":"Mount Sinai J. Med."},{"key":"10.1016\/j.nbd.2018.12.022_bb0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNF.0b013e3181ebb285","article-title":"Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease","volume":"33","author":"Lundin","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0200","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","article-title":"Sigma-1R agonist improves motor function and motoneuron survival in ALS mice","volume":"9","author":"Mancuso","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2018.12.022_bb0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","article-title":"The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus","volume":"578","author":"Martina","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000101990","article-title":"Sigma receptor type 1 gene variation in a group of polish patients with Alzheimer's disease and mild cognitive impairment","volume":"23","author":"Maruszak","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2018.12.022_bb0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature02617","article-title":"Structural basis of long-term potentiation in single dendritic spines","volume":"429","author":"Matsuzaki","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.12.022_bb0220","first-page":"81","article-title":"Sigma-1 (\u03c31) receptor in memory and neurodegenerative diseases","volume":"244","author":"Maurice","year":"2017","journal-title":"Sigma Proteins"},{"key":"10.1016\/j.nbd.2018.12.022_bb0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(96)00160-1","article-title":"Neuroprotective and anti-amnesic potentials of sigma (\u03c3) receptor ligands","volume":"21","author":"Maurice","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2018.12.022_bb0235","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.pbb.2006.07.009","article-title":"Neuro (active) steroids actions at the neuromodulatory sigma 1 (\u03c3 1) receptor: biochemical and physiological evidences, consequences in neuroprotection","volume":"84","author":"Maurice","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2018.12.022_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.11.010","article-title":"Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the \u03c31 receptor","volume":"339","author":"Maurice","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2018.12.022_bb0245","first-page":"1034","article-title":"Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor","volume":"17","author":"Mavlyutov","year":"2011","journal-title":"Mol. Vision"},{"key":"10.1016\/j.nbd.2018.12.022_bb0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2013.02.035","article-title":"Lack of sigma-1 receptor exacerbates ALS progression in mice","volume":"240","author":"Mavlyutov","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.12.022_bb0255","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.109.160960","article-title":"Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor \u03baB","volume":"332","author":"Meunier","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2018.12.022_bb0260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0265","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/j.1460-9568.2007.05911.x","article-title":"Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y","volume":"26","author":"Meurs","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma1 receptors in early Alzheimer's disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.nbd.2018.12.022_bb0275","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","article-title":"N-methyl-D-aspartate-induced neuronal activation is selectively modulated by \u03c3 receptors","volume":"179","author":"Monnet","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0280","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1073\/pnas.92.9.3774","article-title":"Neurosteroids, via sigma receptors, modulate the [3H] norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus","volume":"92","author":"Monnet","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0285","doi-asserted-by":"crossref","first-page":"e60863","DOI":"10.1371\/journal.pone.0060863","article-title":"Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice","volume":"8","author":"Moriguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.12.022_bb0290","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/319774a0","article-title":"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5","volume":"319","author":"Morris","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.12.022_bb0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0197-0186(97)00105-8","article-title":"Activation of \u03c3 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures","volume":"32","author":"Nakazawa","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2018.12.022_bb0300","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI30447","article-title":"Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1","volume":"117","author":"Nelson","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2018.12.022_bb0305","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.pnpbp.2004.05.004","article-title":"The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition","volume":"28","author":"Nilsson","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0310","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuron.2005.03.015","article-title":"Spine-neck geometry determines NMDA receptor-dependent Ca2+ signaling in dendrites","volume":"46","author":"Noguchi","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.12.022_bb0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","article-title":"SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models","volume":"559","author":"Ono","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2018.12.022_bb0320","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.febslet.2015.01.033","article-title":"Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor","volume":"589","author":"Ortega-Roldan","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2018.12.022_bb0325","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","article-title":"NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus","volume":"34","author":"Pabba","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0330","doi-asserted-by":"crossref","first-page":"17625","DOI":"10.1038\/s41598-017-17762-8","article-title":"Stim2-Eb3 association and morphology of dendritic spines in hippocampal neurons","volume":"7","author":"Pchitskaya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2018.12.022_bb0335","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.12.022_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-015-0034-7","article-title":"STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity","volume":"10","author":"Popugaeva","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.12.022_bb0345","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.neuropharm.2011.01.051","article-title":"Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices","volume":"60","author":"Rammes","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.12.022_bb0350","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuropharm.2014.12.037","article-title":"MRZ-99030 - a novel modulator of Abeta aggregation: II - Reversal of Abeta oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice","volume":"92","author":"Rammes","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.12.022_bb0355","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2018.07.021","article-title":"The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A\u03b2) species on long-term potentiation (LTP)","volume":"140","author":"Rammes","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.12.022_bb0360","doi-asserted-by":"crossref","first-page":"e1997","DOI":"10.1371\/journal.pone.0001997","article-title":"Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images","volume":"3","author":"Rodriguez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.12.022_bb0365","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00702-008-0038-3","article-title":"Effects of (\u2212)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization","volume":"115","author":"Rung","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2018.12.022_bb0370","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awq367","article-title":"The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke","volume":"134","author":"Ruscher","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.12.022_bb0375","series-title":"Neurodegenerative Diseases: Unifying Principles","article-title":"Calcium Hypothesis of Neurodegeneration","volume":"Vol. 27","author":"Ryskamp","year":"2016"},{"key":"10.1016\/j.nbd.2018.12.022_bb0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","article-title":"The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease","volume":"97","author":"Ryskamp","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/mp.2012.3","article-title":"The dopamine stabilizers ACR16 and (\u2212)-OSU6162 display nanomolar affinities at the sigma-1 receptor","volume":"18","author":"Sahlholm","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0390","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","article-title":"Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses","volume":"232","author":"Sahlholm","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2018.12.022_bb0395","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0400","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2018.12.022_bb0405","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.12.022_bb0410","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human sigma1 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.12.022_bb0415","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.12.022_bb0420","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1167\/iovs.08-1824","article-title":"In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine","volume":"49","author":"Smith","year":"2008","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0425","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.13695","article-title":"Sigma receptor type 1 knockout mice show a mild deficit in plasticity but no significant change in synaptic transmission in the CA 1 region of the hippocampus","volume":"138","author":"Snyder","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.12.022_bb0430","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/jcmm.12604","article-title":"Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6\/2 mouse model","volume":"19","author":"Squitieri","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2018.12.022_bb0435","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.201506022","article-title":"Sigma1 receptors inhibit store-operated Ca2+ entry by attenuating coupling of STIM1 to Orai1","volume":"213","author":"Srivats","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0440","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0445","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000086426","article-title":"Hippocampal spatial memory impairments caused by the familial Alzheimer's disease-linked presenilin 1 M146V mutation","volume":"2","author":"Sun","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0450","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuron.2014.02.019","article-title":"Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice","volume":"82","author":"Sun","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.12.022_bb0455","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/156720509788486554","article-title":"Thin, stubby or mushroom: spine pathology in Alzheimer's disease","volume":"6","author":"Tackenberg","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2018.12.022_bb0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.conb.2005.12.001","article-title":"Molecular mechanisms of dendritic spine morphogenesis","volume":"16","author":"Tada","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0465","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-2004-832679","article-title":"A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors","volume":"37","author":"Takebayashi","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.12.022_bb0475","doi-asserted-by":"crossref","first-page":"22468","DOI":"10.1073\/pnas.0909089106","article-title":"Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway","volume":"106","author":"Tsai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.12.022_bb0480","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/syn.20984","article-title":"Insights into the Sigma-1 receptor chaperone's cellular functions: a microarray report","volume":"66","author":"Tsai","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2018.12.022_bb0485","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1073\/pnas.1422001112","article-title":"Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid","volume":"112","author":"Tsai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.12.022_bb0490","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","article-title":"Presenilins form ER calcium leak channels, a function disrupted by mutations linked to familial Alzheimer's disease","volume":"126","author":"Tu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.12.022_bb0495","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cell.2006.06.059","article-title":"Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations","volume":"126","author":"Tu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.12.022_bb0500","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00019442-200512000-00005","article-title":"A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease","volume":"13","author":"Uchida","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2018.12.022_bb0505","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Gene. Med."},{"key":"10.1016\/j.nbd.2018.12.022_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-170267","article-title":"Pridopidine: Overview of Pharmacology and Rationale for its use in Huntington's Disease","volume":"7","author":"Waters","year":"2018","journal-title":"J. Huntington's Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chembiol.2011.04.012","article-title":"Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment","volume":"18","author":"Wu","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.nbd.2018.12.022_bb0520","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.1038-15.2016","article-title":"Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington's disease mouse model","volume":"36","author":"Wu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0525","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JHD-170266","article-title":"Inhibition of TRPC1-dependent store-operated calcium entry improves synaptic stability and motor performance in a mouse model of Huntington's disease","volume":"7","author":"Wu","year":"2018","journal-title":"J. Huntington's Dis."},{"key":"10.1016\/j.nbd.2018.12.022_bb0530","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0535","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1523\/JNEUROSCI.1034-15.2015","article-title":"Neuronal store-operated calcium entry and mushroom spine loss in amyloid precursor protein knock-in mouse model of Alzheimer's disease","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.12.022_bb0540","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1523\/JNEUROSCI.1188-16.2016","article-title":"Store-Operated Calcium Channel complex in Postsynaptic Spines: a New Therapeutic Target for Alzheimer's Disease Treatment","volume":"36","author":"Zhang","year":"2016","journal-title":"J. Neurosci."}],"updated-by":[{"DOI":"10.1016\/j.nbd.2026.107311","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000}},{"DOI":"10.1016\/j.nbd.2026.107311","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118305953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118305953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:42:35Z","timestamp":1565228555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118305953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":108,"alternative-id":["S0969996118305953"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.12.022","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}